Lilly launches direct-to-patient delivery of Mounjaro in Australia
October 2, 2026
AI summary — for doctors, generated from the source snippet
Why it matters
Eli Lilly is delivering Mounjaro directly to patients in Australia, and local doctors and pharmacists are unhappy about being bypassed.
Clinical relevance
Shows how access to incretin therapies may shift away from pharmacies and prescribers' usual dispensing channels.
Who should care
This is an AI-generated summary of the source's own press release/snippet, not a clinical recommendation. Verify against the original source before acting on it.
Original source summary
Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and pharmacists aren’t thrilled.
Verbatim from STAT's own feed — "STAT+: Lilly bypasses Australian pharmacies with DTC model"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news